IM Cannabis Corp. completed the sale of all issued and outstanding shares of IMC Holdings Ltd. to Slil.com Holding Ltd. on September 29, 2026, after the closing conditions were satisfied or waived. Before closing, the company transferred its Israeli operations out of IMC Holdings and retained them. IMC Holdings was left holding equity interests in Adjupharm GmbH, Xinteza API Ltd. and Shiran Societe Anonyme, along with retained liabilities. Management’s preliminary unaudited analysis indicates the transaction could improve shareholders’ equity by approximately C$3 million, although the final accounting effect may differ. The consideration comprised a previously paid C$3 million advance and Slil’s assumption of IMC Holdings with its retained liabilities, which were capped at C$9.4 million under the agreement, excluding direct liabilities of the target subsidiaries. The transaction was a related-party transaction under MI 61-101 (Canadian minority-holder protection rules) because Slil is controlled by Oren Shuster, IM Cannabis’s Chief Executive Officer, director, securityholder and debtholder. A special committee of independent directors recommended approval, while Shuster declared his interest and did not participate in or vote on the approval.